As of 2025-12-19, the Relative Valuation of Novavax Inc (NVAX) is 37.12 USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.68 USD, the upside of Novavax Inc based on Relative Valuation is 455.7%.
The range of the Relative Valuation is 36.17 - 41.43 USD.
| Range | Selected | |
| Trailing P/E multiples | 17.2x - 18.8x | 17.2x |
| Forward P/E multiples | 17.6x - 19.7x | 18.1x |
| Fair Price | 36.17 - 41.43 | 37.12 |
| Upside | 441.5% - 520.2% | 455.7% |
| Date | P/E |
| 2025-12-17 | 3.11 |
| 2025-12-16 | 3.11 |
| 2025-12-15 | 3.13 |
| 2025-12-12 | 3.12 |
| 2025-12-11 | 3.18 |
| 2025-12-10 | 3.20 |
| 2025-12-09 | 3.17 |
| 2025-12-08 | 3.22 |
| 2025-12-05 | 3.29 |
| 2025-12-04 | 3.26 |
| 2025-12-03 | 3.25 |
| 2025-12-02 | 3.14 |
| 2025-12-01 | 3.18 |
| 2025-11-28 | 3.35 |
| 2025-11-26 | 3.30 |
| 2025-11-25 | 3.18 |
| 2025-11-24 | 3.15 |
| 2025-11-21 | 3.08 |
| 2025-11-20 | 2.96 |
| 2025-11-19 | 3.01 |
| 2025-11-18 | 3.12 |
| 2025-11-17 | 3.23 |
| 2025-11-14 | 3.31 |
| 2025-11-13 | 3.36 |
| 2025-11-12 | 3.42 |
| 2025-11-11 | 3.54 |
| 2025-11-10 | 3.38 |
| 2025-11-07 | 3.54 |
| 2025-11-06 | 3.61 |
| 2025-11-05 | 3.66 |
| 2025-11-04 | 3.57 |
| 2025-11-03 | 3.76 |
| 2025-10-31 | 3.99 |
| 2025-10-30 | 4.01 |
| 2025-10-29 | 3.98 |
| 2025-10-28 | 4.05 |
| 2025-10-27 | 4.14 |
| 2025-10-24 | 4.05 |
| 2025-10-23 | 3.98 |
| 2025-10-22 | 4.02 |
| 2025-10-21 | 4.08 |
| 2025-10-20 | 4.18 |
| 2025-10-17 | 3.85 |
| 2025-10-16 | 4.03 |
| 2025-10-15 | 4.24 |
| 2025-10-14 | 4.23 |
| 2025-10-13 | 4.10 |
| 2025-10-10 | 3.96 |
| 2025-10-09 | 4.08 |
| 2025-10-08 | 4.23 |